Cargando…
Enhanced IFNα Signaling Promotes Ligand-Independent Activation of ERα to Promote Aromatase Inhibitor Resistance in Breast Cancer
SIMPLE SUMMARY: Interferon alpha (IFNα) signaling is highly upregulated in ER+ breast cancers that become resistant to estrogen deprivation therapy. This study uncovers how enhanced (IFNα)/JAK-STAT signaling directly influences estrogen receptor (ERα) activation in the absence of estrogen. We found...
Autores principales: | Escher, Taylor E., Dandawate, Prasad, Sayed, Afreen, Hagan, Christy R., Anant, Shrikant, Lewis-Wambi, Joan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534010/ https://www.ncbi.nlm.nih.gov/pubmed/34680281 http://dx.doi.org/10.3390/cancers13205130 |
Ejemplares similares
-
Prolactin receptor signaling: A novel target for cancer treatment - Exploring anti-PRLR signaling strategies
por: Standing, David, et al.
Publicado: (2023) -
Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells
por: Lui, Asona, et al.
Publicado: (2016) -
Super-enhancer-controlled positive feedback loop BRD4/ERα–RET–ERα promotes ERα-positive breast cancer
por: Zheng, Zao-zao, et al.
Publicado: (2022) -
Celastrol and Triptolide Suppress Stemness in Triple Negative Breast Cancer: Notch as a Therapeutic Target for Stem Cells
por: Ramamoorthy, Prabhu, et al.
Publicado: (2021) -
Type I IFN stimulates IFI16-mediated aromatase expression in adipocytes that promotes E(2)-dependent growth of ER-positive breast cancer
por: Ka, Na-Lee, et al.
Publicado: (2022)